Millennium Management’s Oncolytics Biotech ONCY Stock Holding History

Millennium Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Buy	+10,541	New	+$9.77K	﹤0.01%	5718
2024 Q2	–	Sell	-40,887	Closed	-$43.3K	–	6351
2024 Q1	$43.3K	Sell	40,887 -86,955	-68%	-$97.2K	﹤0.01%	5704
2023 Q4	$173K	Sell	127,842 -85,181	-40%	-$133K	﹤0.01%	5223
2023 Q3	$464K	Buy	+213,023	New	+$520K	﹤0.01%	4708
2023 Q1	–	Sell	-25,689	Closed	-$42K	–	6715
2022 Q4	$42K	Buy	+25,689	New	+$39K	﹤0.01%	5839
2018 Q4	–	Sell	-46,563	Closed	-$180K	–	4062
2018 Q3	$180K	Sell	46,563 -442,968	-90%	-$2.06M	﹤0.01%	3662
2018 Q2	$2.69M	Buy	+489,531	New	+$3.01M	﹤0.01%	2204

Other funds holding ONCY

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Millennium Management's ONCY Position: Q2 2026 in Review

Millennium Management opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 10,541 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #5718 among its holdings. This is a return to the name: Millennium Management previously reported a position in ONCY as recently as Q1 2024.

Millennium Management first reported a position in ONCY in Q2 2018 and has held it in 7 quarters since. The position peaked at $2.69M in Q2 2018. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Millennium Management held 10,541 shares of Oncolytics Biotech worth $10K as of Q2 2026.
Oncolytics Biotech was a new Millennium Management position in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5718 holding.
Millennium Management first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 7 quarters since.
Millennium Management's Oncolytics Biotech position peaked at $2.69M in Q2 2018.
75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.